Suven Life Sciences Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 8.30 | 5.57 | 4.70 |
| Operating Expense | 17.72 | 17.70 | 18.83 |
| Net Profit | -11.17 | -13.47 | -15.45 |
| Net Profit Margin | -134.58% | -241.83% | -328.72% |
| Earning Per Share | -0.50 | -0.60 | -0.70 |
| EBIDTA | -9.43 | -12.12 | -14.13 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Mar 2026
Revenue8.30
Operating Expense17.72
Net Profit-11.17
Net Profit Margin-134.58
Earning Per Share-0.50
EBIDTA-9.43
Effective Tax Rate-0
